Proteome-Wide Target Identification Using Reactive Metallo-Scaffolds (r-mS): A Platform for Metallodrug Discovery
Authors:
- Jessica E. WatersJWJessica E. Waters
- George S. BiggsGBGeorge S. Biggs
- Harry WildersHWHarry Wilders
- Emma E. CawoodECEmma E. Cawood
- Jonathan BaileyJBJonathan Bailey
- Mika KintzelMKMika Kintzel
- Sarah MaslenSMSarah Maslen
- Yew Mun YipYYYew Mun Yip
- Mason WakleyMWMason Wakley
- Joanna RedmondJRJoanna Redmond
- J. Mark SkehelJSJ. Mark Skehel
- David HouseDHDavid House
Preprint
- 22 September 2025
- preprint
- Published by American Chemical Society (ACS) in ChemRxiv
Abstract
Metal complexes offer unique opportunities as scaffolds in chemical biology and drug discovery, with tuneable geometry, modular coordination environments, and structural features not readily accessible with organic molecules. Here, we introduce reactive metallo-scaffolds (r-mS) - a new class of covalent warhead-containing metal complexes - designed to map ligandable cysteines across the mammalian proteome. Using chemoproteomics, we profiled a focused r-mS series in HEK293T lysate, identifying novel cysteine ligandability and demonstrating how metal identity, arene substituents and overall molecular topography govern cysteine reactivity and proteome-wide targeting. Among the series screened, r-mS-2 emerged as the most productive scaffold, which engaged cysteine 119 within the functionally relevant SAM binding domain of PRMT1. This interaction was validated via intact protein LC-MS and was determined to functionally inhibit the activity of PRMT1. Structural modelling and docking provided insights into the molecular basis of binding, which implied π-stacking and electrostatic complementarity in driving covalent engagement. Together, these results position reactive metallo-scaffolds as a versatile platform for proteome-wide covalent ligand discovery and the rational development of next-generation metallodrugs.Keywords
All Related Versions
Funding Information
- Wellcome (CC2215)
- Engineering and Physical Sciences Research Council (EP/V038028/1)
This publication has 64 references indexed in Scilit:
- Protein Arginine Methyltransferases from Regulatory Function to Clinical Implication in Central Nervous SystemCellular and Molecular Neurobiology, 2025
- Exploring BIRC family genes as prognostic biomarkers and therapeutic targets in prostate cancerDiscover Oncology, 2025
- Interaction with Ribosomal Proteins Accompanies Stress Induction of the Anticancer Metallodrug BOLD‐100/KP1339 in the Endoplasmic ReticulumAngewandte Chemie International Edition, 2020
- Protein Arginine Methyltransferases in Cardiovascular and Neuronal FunctionMolecular Neurobiology, 2019
- Tetrathiafulvalene‐Based Phenanthroline Ligands: Synthesis, Crystal Structures, and Electronic PropertiesEuropean Journal of Inorganic Chemistry, 2014
- Identification of KLHL41 Mutations Implicates BTB-Kelch-Mediated Ubiquitination as an Alternate Pathway to Myofibrillar Disruption in Nemaline MyopathyThe American Journal of Human Genetics, 2013
- Ferrocene labelings as inhibitors and dual electrochemical sensors of human glutathione S-transferase P1-1Bioorganic & Medicinal Chemistry Letters, 2012
- Dysregulation of PRMT1 and PRMT6, Type I arginine methyltransferases, is involved in various types of human cancersInternational Journal of Cancer, 2010
- Synthesis, Biochemical Properties and Molecular Modelling Studies of Organometallic Specific Estrogen Receptor Modulators (SERMs), the Ferrocifens and Hydroxyferrocifens: Evidence for an Antiproliferative Effect of Hydroxyferrocifens on both Hormone‐Dependent and Hormone‐Independent Breast Cancer Cell LinesChemistry – A European Journal, 2003
- Long-Lifetime Ru(II) Complexes as Labeling Reagents for Sulfhydryl GroupsAnalytical Biochemistry, 1998